Baidu
map
J NEURORESTORATOLOGY 润色咨询

Journal of Neurorestoratology

出版年份：暂无数据 年文章数：87 投稿命中率： 开通期刊会员，数据随心看

出版周期：暂无数据 自引率：暂无数据 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2152339, encodeId=55be2152339c0, content=审稿速度:1.0 | 投稿命中率:50.0 | 影响因子:3.3<br>经验分享：不错的期刊，有水平，有望上涨<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a><a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=1, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛), TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11625447534, createdName=ms8000000975418154, createdTime=Fri Aug 11 22:02:10 CST 2023, time=2023-08-11, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1123407, encodeId=0cdc112340ef8, content=投稿时候是否一定要提供每个作者的ORCIDID?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:57 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1123408, encodeId=b6cb1123408d7, content=什么是MS?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:57 CST 2021, time=2021-12-27, status=1, ipAttribution=)]
    2023-08-11 ms8000000975418154 来自陕西省

    审稿速度:1.0 | 投稿命中率:50.0 | 影响因子:3.3
    经验分享：不错的期刊，有水平，有望上涨#期刊论坛##Neurol#

    1

    展开1条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2152339, encodeId=55be2152339c0, content=审稿速度:1.0 | 投稿命中率:50.0 | 影响因子:3.3<br>经验分享：不错的期刊，有水平，有望上涨<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a><a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=1, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛), TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11625447534, createdName=ms8000000975418154, createdTime=Fri Aug 11 22:02:10 CST 2023, time=2023-08-11, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1123407, encodeId=0cdc112340ef8, content=投稿时候是否一定要提供每个作者的ORCIDID?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:57 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1123408, encodeId=b6cb1123408d7, content=什么是MS?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:57 CST 2021, time=2021-12-27, status=1, ipAttribution=)]
    2021-12-28 msSSSSSD

    投稿时候是否一定要提供每个作者的ORCIDID?

    1

    展开1条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2152339, encodeId=55be2152339c0, content=审稿速度:1.0 | 投稿命中率:50.0 | 影响因子:3.3<br>经验分享：不错的期刊，有水平，有望上涨<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a><a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=1, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛), TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11625447534, createdName=ms8000000975418154, createdTime=Fri Aug 11 22:02:10 CST 2023, time=2023-08-11, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1123407, encodeId=0cdc112340ef8, content=投稿时候是否一定要提供每个作者的ORCIDID?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:57 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1123408, encodeId=b6cb1123408d7, content=什么是MS?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:57 CST 2021, time=2021-12-27, status=1, ipAttribution=)]
    2021-12-27 学医的彭于晏

    什么是MS?

    1

    展开1条回复
共6条页码: 1/1页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分

Baidu
Baidu
map
Baidu
map
Baidu
map